Refresh

Remus Pharmaceuticals Ltd.

Remus Pharmaceuticals Ltd. is not listed on BSE

© 2026 Rediff.com
Price on NSE   04 Feb,15:29 LIVE
663.00
+18.65
(+2.89%)

© 2026 Rediff.com
  • Volume :
  • 4,300.00
  • Prev Close :
  • 644.35
  • Day's H/L (Rs.) :
  • 680.00 - 644.00
  • 52wk H/L (Rs.) :
  • 1,163.50 - 611.05
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Remus Pharmaceuticals Ltd.
PE Ratios
EPS (Rs.)
33.79
Sales (Rs. Cr)
Face Value (Rs.)
10
Net Profit Margin(%)
25.13
Last Bonus
1:1
Last Dividend(%)
5
Return on Average Equity
8.21

News for Pharmaceuticals and health care

Cigarette Tax Hike: Illicit Trade & Tax Collection Impact
Report warns high cigarette taxes may fuel illicit trade, hurting tax collection. Excise duty impact on tobacco farmers & industry analyzed.
Feb 04, 2026 16:02
Rupee Falls Against US Dollar After Trade Deal Rally
Rupee depreciates to 90.43 against the US dollar after India-US trade deal rally. Investors await clarity on deal terms.
Feb 04, 2026 15:51
Zydus Gets USFDA Nod for Diabetes Drug
Zydus Lifesciences receives USFDA approval for generic Dapagliflozin tablets, a diabetes drug, for the US market. Boost for glycaemic control.
Feb 04, 2026 15:47
Coal Import Plunges 54% for Power Sector Blending
Coal imports for power sector blending in India fell 54% in Apr-Dec. Reduced input costs for domestic coal-based power plants.
Feb 04, 2026 15:38
ACME Solar Appoints Rahul Kaushik as Head
ACME Solar Holdings appoints Rahul Kaushik as Head of Process Transformation. He will focus on risk management and operational excellence.
Feb 04, 2026 15:32

More News »

Top News

Cigarette Tax Hike: Illicit Trade & Tax Collection Impact
Report warns high cigarette taxes may fuel illicit trade, hurting tax collection. Excise duty impact on tobacco farmers & industry analyzed.
Feb 04, 2026 16:02
Rupee Falls Against US Dollar After Trade Deal Rally
Rupee depreciates to 90.43 against the US dollar after India-US trade deal rally. Investors await clarity on deal terms.
Feb 04, 2026 15:51
Zydus Gets USFDA Nod for Diabetes Drug
Zydus Lifesciences receives USFDA approval for generic Dapagliflozin tablets, a diabetes drug, for the US market. Boost for glycaemic control.
Feb 04, 2026 15:47
Fujiyama Power Systems Q3 Profit Jumps Two-Fold
Fujiyama Power Systems reports a two-fold increase in net profit to Rs 67.3 crore in Q3 2025, driven by higher revenues and solar cell manufacturing.
Feb 04, 2026 15:41
Coal Import Plunges 54% for Power Sector Blending
Coal imports for power sector blending in India fell 54% in Apr-Dec. Reduced input costs for domestic coal-based power plants.
Feb 04, 2026 15:38

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com